| Authors: |
Garcia-Murillas I; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Abbott CW; Personalis Inc., Fremont, USA., Cutts RJ; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Boyle SM; Personalis Inc., Fremont, USA., Pugh J; Personalis Inc., Fremont, USA., Keough KC; Personalis Inc., Fremont, USA., Li B; Personalis Inc., Fremont, USA., Pyke RM; Personalis Inc., Fremont, USA., Navarro FCP; Personalis Inc., Fremont, USA., Chen RO; Personalis Inc., Fremont, USA., Dunne K; The Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, UK., Bunce C; Clinical Trials Unit, Royal Marsden Hospital, London, UK., Johnston SRD; Breast Unit, Royal Marsden Hospital, London, UK., Ring A; Breast Unit, Royal Marsden Hospital, London, UK., Russell S; Hinchingbrooke Hospital, Hinchingbrooke Park, Huntingdon, UK., Evans A; Poole General Hospital, Dorset, UK., Skene A; Royal Bournemouth Hospital, Bournemouth, UK., Smith IE; Breast Unit, Royal Marsden Hospital, London, UK., Turner NC; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK; The Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, UK; Breast Unit, Royal Marsden Hospital, London, UK. Electronic address: nick.turner@icr.ac.uk. |
